Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HYALOGYN (marketed as HYALO GYN) is a non-hormonal vaginal moisturizer and personal lubricant formulated with Hydeal-D, a proprietary hyaluronic acid derivative. It is designed to hydrate and lubricate the vaginal epithelium by leveraging the strong hydrating properties of its main component. The product is available as a colorless, odorless, transparent aqueous gel or as suppositories. Its mechanism relies on the mucoadhesive and water-retaining characteristics of hyaluronic acid derivatives to supplement natural lubrication and provide long-lasting hydration for women experiencing vaginal dryness due to menopause or other causes. The formulation does not contain parabens or hormones and is compatible with latex, polyurethane, and natural skin condoms[1][2][5][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HYALOGYN.